Bayer Aktiengesellschaft (LON:0P6S)

Market Cap	21.50B
Revenue (ttm)	38.97B
Net Income (ttm)	-2.72B
Shares Out	n/a
EPS (ttm)	-2.78
PE Ratio	n/a
Forward PE	5.54
Dividend	0.09 (0.34%)
Ex-Dividend Date	Apr 28, 2025

Volume	2,126,649
Average Volume	1,589,585
Open	27.00
Previous Close	26.94
Day's Range	26.86 - 27.47
52-Week Range	18.37 - 31.04
Beta	0.98
RSI	45.84
Earnings Date	Aug 6, 2025

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skin...

• Industry: Chemicals and Allied Products
• Founded: 1863
• Employees: 91,864
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0P6S

Financial Performance

In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.

Financial numbers in EUR